SMTL ID : 7jv8.3 (3 other biounits)

Human CD73 (ecto 5'-nucleotidase) in complex with compound 35

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: D.14, H.16, D.63 Ligands: ZN.2, VPD.4 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.14, A:H.16, A:D.63, H2O.1 ZN.2: 7 residues within 4Å: Chain A: D.14, D.63, N.95, H.198, H.221 Ligands: ZN.1, VPD.4 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.63, A:H.198, A:H.221

1 x CA: CALCIUM ION(Non-covalent)

CA.3: 3 residues within 4Å: Chain A: N.191, D.215, G.276 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:N.191, A:D.215, A:D.215, A:G.276, H2O.1

1 x VPD: 6-chloro-N-cyclopentyl-1-{5-O-[(2R)-1-hydroxy-3-methoxy-2-phosphonopropan-2-yl]-beta-D-ribofuranosyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine(Non-covalent)

VPD.4: 21 residues within 4Å: Chain A: D.14, H.16, D.63, N.95, H.96, D.99, L.162, N.164, H.198, H.221, R.332, N.368, G.370, G.371, R.373, F.395, G.425, F.478, D.484 Ligands: ZN.1, ZN.2 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.478 Hydrogen bonds: A:N.95, A:N.95, A:R.332, A:R.332, A:N.368, A:G.370, A:R.373, A:R.373, A:G.425, A:D.484 Water bridges: A:N.223 pi-Stacking: A:F.395, A:F.395, A:F.478, A:F.478

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Du, X. et al., Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production. J.Med.Chem. (2020)

Release Date

2020-09-23

Peptides

5'-nucleotidase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

5'-nucleotidase

Related Entries With Identical Sequence